A Phase II Open-Labeled Study to Evaluate BFPET as a Myocardial Perfusion Imaging Agent for the Evaluation of Coronary Artery Disease

Trial Profile

A Phase II Open-Labeled Study to Evaluate BFPET as a Myocardial Perfusion Imaging Agent for the Evaluation of Coronary Artery Disease

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Aug 2017

At a glance

  • Drugs BFPET (Primary)
  • Indications Coronary artery disease
  • Focus Diagnostic use
  • Sponsors FluoroPharma
  • Most Recent Events

    • 31 Jul 2017 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
    • 31 Jul 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
    • 31 Jul 2017 Planned initiation date changed from 1 May 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top